BOE
JAZZ icon

Bank of Edwardsville’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bank of Edwardsville’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,182
Closed -$454K – 41
2019
Q2 		$454K Sell
3,182
-23
-0.7% -$3.09K 0.57% 47
2019
Q1 		$458K Buy
+3,205
New +$418K 0.7% 48

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of Edwardsville's JAZZ Position: Q3 2019 in Review

Bank of Edwardsville sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2019, closing a stake of 3,182 shares — an estimated $454K sold.

Bank of Edwardsville first reported a position in JAZZ in Q1 2019 and held it in 2 quarters. The position peaked at $458K in Q1 2019. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

  • Bank of Edwardsville reported no remaining Jazz Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Bank of Edwardsville sold 3,182 Jazz Pharmaceuticals shares in Q3 2019, an estimated $454K.
  • Bank of Edwardsville first reported a position in Jazz Pharmaceuticals in Q1 2019 and held it in 2 quarters.
  • Bank of Edwardsville's Jazz Pharmaceuticals position peaked at $458K in Q1 2019.
  • 406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Bank of Edwardsville's 13F filing for Q3 2019.